Chase-Logeman Corporation: Liquid filling barrier isolator system

Chase-Logeman’s ChaseGuard™ Liquid Filling Barrier Isolator System offers a high level of aseptic processing and operator protection for cGMP pharmaceutical applications such as R&D, Pilot Plant, Clinical Trial, and smaller production batch processes.

Pw 7421 Webchase
In partnership, Chase-Logeman Corporation and EnGuard Systems have combined their experience of liquid filling and barrier isolation to offer this system at a competitive cost and quality service. ChaseGuard’s tool-free system offers a platform of “standard” modular designs for Liquid Fill & Stopper, as well as Liquid Fill, Stopper & AL Crimp Sealing. This unique standard design method provides lower equipment cost, but also delivers the benefits of enhanced delivery and validation time-lines. A complete line of Transport Docking Isolator units, which can be utilized for transporting vials, stoppers, crimps, change parts, and associated items, is also available.
Fill out the form below to request more information about Chase-Logeman Corporation: Liquid filling barrier isolator system
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report